Ampersand Capital Partners Makes Majority Investment in Tjoapack
April 21, 2020
Ampersand Capital Partners has made a majority investment in Tjoapack Netherlands B.V., a global contract packaging organisation serving the pharmaceutical industry. The investment will fund expansion of Tjoapack's automated packaging capabilities (including injectable products and pre-filled syringes); Dexter Tjoa has been appointed CEO while founder Eric Tjoa remains on the board.
- Buyers
- Ampersand Capital Partners
- Targets
- Tjoapack Netherlands B.V.
- Industry
- Pharmaceuticals
- Location
- North Brabant, Netherlands
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.